Newamsterdam Pharma Company N.V. (NAMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,179 | 3,249 | 1,519 | 2,818 | -127 |
| Accounts payable and accrued liabilities | 5 | -117 | -98 | -1 | N/A |
| Other Working Capital | 228 | 182 | -33 | 35 | -416 |
| Other Operating Activity | -4,550 | -4,043 | -1,964 | -3,055 | 43 |
| Operating Cash Flow | $-138 | $-730 | $-576 | $-203 | $-500 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | 0 | 0 | -138,000 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-138,000 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 0 | 0 | 139,865 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $139,865 |
| Beginning Cash Position | 1,365 | 1,365 | 1,365 | 1,365 | 0 |
| End Cash Position | 1,227 | 636 | 790 | 1,163 | 1,365 |
| Net Cash Flow | $-138 | $-730 | $-576 | $-203 | $1,365 |
| Free Cash Flow | |||||
| Operating Cash Flow | -138 | -730 | -576 | -203 | -500 |
| Free Cash Flow | -138 | -730 | -576 | -203 | -500 |